Literature DB >> 17451884

Selenocysteine beta-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide.

Kazuo T Suzuki1, Kazuki Kurasaki, Noriyuki Suzuki.   

Abstract

The lyase activity toward Se-methylated selenoamino acids and the demethylase activity toward methylselenol in the metabolism of selenium were characterized in vitro. The beta- and gamma-lyase activities toward selenomethionine (SeMet) and Se-methylselenocysteine (MeSeCys), respectively, were compared under exactly identical conditions by incubating 77Se-SeMet and 76Se-MeSeCys simultaneously in a liver supernatant, and then estimated by the decreases in the labeled starting selenoamino acids (MeSeCys and SeMet), and also by the increases in the labeled enzyme products (methylselenol and selenide) after oxidation to methylseleninic acid (MSA(IV)) and selenite, respectively, by HPLC-inductively coupled plasma-mass spectrometry (ICP-MS). Only 76Se-MeSeCys was decreased and only 76Se-selenite was produced, suggesting that conversion of MeSeCys to methylselenol by beta-lyase followed by that of methylselenol to selenide by demethylase actively occurred in the liver supernatant. The demethylase activity was characterized by incubating 77Se-methylselenol produced in situ from 77Se-MSA(IV) and glutathione in a partially purified enzyme preparation. It was found that demethylation takes place directly through an attack by a hydroxide anion on the methyl group of methylselenol producing selenide and methanol, selenide being detected on HPLC-ICP-MS after oxidation to selenite, and methanol on GC-MS. It was concluded that beta- but not gamma-lyase activity could be detected in a liver supernatant, and that the resulting methylselenol product is demethylated through hydrolysis, with methanol and selenide being produced (MeSeCys-->CH3SeH-->HSeH + CH3OH).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451884     DOI: 10.1016/j.bbagen.2007.03.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.

Authors:  Christopher H Miller; Shahista Nisa; Sandi Dempsey; Cameron Jack; Ronan O'Toole
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

2.  The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2D.

Authors:  Michael Hagemann-Jensen; Franziska Uhlenbrock; Stephanie Kehlet; Lars Andresen; Charlotte Gabel-Jensen; Lars Ellgaard; Bente Gammelgaard; Søren Skov
Journal:  J Biol Chem       Date:  2014-09-25       Impact factor: 5.157

3.  The integrative analysis of DNA methylation and mRNA expression profiles confirmed the role of selenocompound metabolism pathway in Kashin-Beck disease.

Authors:  Ping Li; Yujie Ning; Weizhuo Wang; Xiong Guo; Blandine Poulet; Xi Wang; Yan Wen; Jing Han; Jingcan Hao; Xiao Liang; Li Liu; Yanan Du; Bolun Cheng; Shiqiang Cheng; Lu Zhang; Mei Ma; Xin Qi; Chujun Liang; Cuiyan Wu; Sen Wang; Hongmou Zhao; Guanghui Zhao; Mary B Goldring; Feng Zhang; Peng Xu
Journal:  Cell Cycle       Date:  2020-08-20       Impact factor: 4.534

4.  Kynurenine aminotransferase III and glutamine transaminase L are identical enzymes that have cysteine S-conjugate β-lyase activity and can transaminate L-selenomethionine.

Authors:  John T Pinto; Boris F Krasnikov; Steven Alcutt; Melanie E Jones; Thambi Dorai; Maria T Villar; Antonio Artigues; Jianyong Li; Arthur J L Cooper
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

5.  Methylselenol producing selenocompounds enhance the efficiency of mammaglobin-A peptide vaccination against breast cancer cells.

Authors:  Duaa Babaer; Mu Zheng; Michael T Ivy; Roy Zent; Venkataswarup Tiriveedhi
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

Review 6.  Cysteine S-conjugate β-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents.

Authors:  Arthur J L Cooper; Boris F Krasnikov; Zoya V Niatsetskaya; John T Pinto; Patrick S Callery; Maria T Villar; Antonio Artigues; Sam A Bruschi
Journal:  Amino Acids       Date:  2010-03-22       Impact factor: 3.520

7.  Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase.

Authors:  Arthur J L Cooper; John T Pinto; Boris F Krasnikov; Zoya V Niatsetskaya; Qian Han; Jianyong Li; David Vauzour; Jeremy P E Spencer
Journal:  Arch Biochem Biophys       Date:  2008-02-29       Impact factor: 4.013

8.  Selenium in the prevention of human cancers.

Authors:  Mikael Björnstedt; Aristi P Fernandes
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

9.  Biochemical discrimination between selenium and sulfur 1: a single residue provides selenium specificity to human selenocysteine lyase.

Authors:  Ruairi Collins; Ann-Louise Johansson; Tobias Karlberg; Natalia Markova; Susanne van den Berg; Kenneth Olesen; Martin Hammarström; Alex Flores; Herwig Schüler; Lovisa Holmberg Schiavone; Peter Brzezinski; Elias S J Arnér; Martin Högbom
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

10.  Methylselenol formed by spontaneous methylation of selenide is a superior selenium substrate to the thioredoxin and glutaredoxin systems.

Authors:  Aristi P Fernandes; Marita Wallenberg; Valentina Gandin; Sougat Misra; Francesco Tisato; Cristina Marzano; Maria Pia Rigobello; Sushil Kumar; Mikael Björnstedt
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.